Loading…
Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review
Objective The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy‐induced cardiomyopathy (CIC). Methods With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, a...
Saved in:
| Published in: | Annals of noninvasive electrocardiology 2023-09, Vol.28 (5), p.e13070-n/a |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4740-c131955db60a9a433e2271032541f08f7b6544263350163ffdb0a3a79fd8187b3 |
| container_end_page | n/a |
| container_issue | 5 |
| container_start_page | e13070 |
| container_title | Annals of noninvasive electrocardiology |
| container_volume | 28 |
| creator | Shehram, Muhammad Khalid, Hiba Shafique, Hafiz Muhammad Umer, Bakht Zafar, Awais Ullah, Asif Zaidi, Syed Muhammad Jawad Basit, Jawad Mehmoodi, Amin Malik, Jahanzeb |
| description | Objective
The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy‐induced cardiomyopathy (CIC).
Methods
With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review.
Results
The five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.
Conclusion
CRT was associated with improvement in all patient parameters with CIC.
The five studies included a total of 169 patients who underwent CRT after CIC, which showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group. |
| doi_str_mv | 10.1111/anec.13070 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ac70d436c4ef4fd68143f04a643f9722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ac70d436c4ef4fd68143f04a643f9722</doaj_id><sourcerecordid>2836297862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4740-c131955db60a9a433e2271032541f08f7b6544263350163ffdb0a3a79fd8187b3</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEoqWw4QFQJDYIKcW32AkbNBoNUKmCDUjdWSe-NB4l8WAnU4UVj8Az8iR4mqGiLPDm-PKfz8c-f5Y9x-gcp_EGBqPOMUUCPchOcclIwQS7epjmqCKFIOjqJHsS4xYhQhgRj7MTKhgtOalPs_3GWqdAzTkMOo9gzTjn3uYKgnag8mDiPKg2-MF9h9H5IR9bE2A3527IVWt6f1z_-vHTDXpSRi-5vp_9DsZ2fpuv8jjH0fQp_wDcO3PzNHtkoYvm2TGeZV_fb76sPxaXnz9crFeXhUpPQIXCFNdlqRuOoAZGqSFEYERJybBFlRUNLxkjnNISYU6t1Q0CCqK2usKVaOhZdrFwtYet3AXXQ5ilBydvN3y4lhBSWZ2RoATSjHLFjGVW8wozahEDnkItCEmsdwtrNzW90coMY4DuHvT-yeBaee33EiMmyqpiifDqSAj-22TiKHsXlem61EE_RUkqmpoiKn647OU_0q2fwpD-Kqk4Ihyxukyq14tKBR9jMPauGozkwRvy4A15640kfvF3_XfSP2ZIArwIblxn5v-g5OrTZr1AfwNbB8ZB</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860260495</pqid></control><display><type>article</type><title>Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>PubMed Central</source><creator>Shehram, Muhammad ; Khalid, Hiba ; Shafique, Hafiz Muhammad ; Umer, Bakht ; Zafar, Awais ; Ullah, Asif ; Zaidi, Syed Muhammad Jawad ; Basit, Jawad ; Mehmoodi, Amin ; Malik, Jahanzeb</creator><creatorcontrib>Shehram, Muhammad ; Khalid, Hiba ; Shafique, Hafiz Muhammad ; Umer, Bakht ; Zafar, Awais ; Ullah, Asif ; Zaidi, Syed Muhammad Jawad ; Basit, Jawad ; Mehmoodi, Amin ; Malik, Jahanzeb</creatorcontrib><description>Objective
The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy‐induced cardiomyopathy (CIC).
Methods
With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review.
Results
The five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.
Conclusion
CRT was associated with improvement in all patient parameters with CIC.
The five studies included a total of 169 patients who underwent CRT after CIC, which showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.</description><identifier>ISSN: 1082-720X</identifier><identifier>EISSN: 1542-474X</identifier><identifier>DOI: 10.1111/anec.13070</identifier><identifier>PMID: 37435629</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>anthracycline ; Breast cancer ; Cancer therapies ; Cardiomyopathy ; Chemotherapy ; Clinical trials ; Demographics ; diastolic dysfunction ; Effectiveness ; ejection fraction ; Heart ; Heart failure ; Leukemia ; Lymphoma ; Mortality ; Observational studies ; Parameters ; Patients ; Quality of life ; Review ; Sarcoma ; Systematic review ; Ventricle</subject><ispartof>Annals of noninvasive electrocardiology, 2023-09, Vol.28 (5), p.e13070-n/a</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4740-c131955db60a9a433e2271032541f08f7b6544263350163ffdb0a3a79fd8187b3</cites><orcidid>0000-0002-9343-4187</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475884/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475884/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,11545,27907,27908,46035,46459,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37435629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shehram, Muhammad</creatorcontrib><creatorcontrib>Khalid, Hiba</creatorcontrib><creatorcontrib>Shafique, Hafiz Muhammad</creatorcontrib><creatorcontrib>Umer, Bakht</creatorcontrib><creatorcontrib>Zafar, Awais</creatorcontrib><creatorcontrib>Ullah, Asif</creatorcontrib><creatorcontrib>Zaidi, Syed Muhammad Jawad</creatorcontrib><creatorcontrib>Basit, Jawad</creatorcontrib><creatorcontrib>Mehmoodi, Amin</creatorcontrib><creatorcontrib>Malik, Jahanzeb</creatorcontrib><title>Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review</title><title>Annals of noninvasive electrocardiology</title><addtitle>Ann Noninvasive Electrocardiol</addtitle><description>Objective
The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy‐induced cardiomyopathy (CIC).
Methods
With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review.
Results
The five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.
Conclusion
CRT was associated with improvement in all patient parameters with CIC.
The five studies included a total of 169 patients who underwent CRT after CIC, which showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.</description><subject>anthracycline</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cardiomyopathy</subject><subject>Chemotherapy</subject><subject>Clinical trials</subject><subject>Demographics</subject><subject>diastolic dysfunction</subject><subject>Effectiveness</subject><subject>ejection fraction</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Leukemia</subject><subject>Lymphoma</subject><subject>Mortality</subject><subject>Observational studies</subject><subject>Parameters</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Review</subject><subject>Sarcoma</subject><subject>Systematic review</subject><subject>Ventricle</subject><issn>1082-720X</issn><issn>1542-474X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEoqWw4QFQJDYIKcW32AkbNBoNUKmCDUjdWSe-NB4l8WAnU4UVj8Az8iR4mqGiLPDm-PKfz8c-f5Y9x-gcp_EGBqPOMUUCPchOcclIwQS7epjmqCKFIOjqJHsS4xYhQhgRj7MTKhgtOalPs_3GWqdAzTkMOo9gzTjn3uYKgnag8mDiPKg2-MF9h9H5IR9bE2A3527IVWt6f1z_-vHTDXpSRi-5vp_9DsZ2fpuv8jjH0fQp_wDcO3PzNHtkoYvm2TGeZV_fb76sPxaXnz9crFeXhUpPQIXCFNdlqRuOoAZGqSFEYERJybBFlRUNLxkjnNISYU6t1Q0CCqK2usKVaOhZdrFwtYet3AXXQ5ilBydvN3y4lhBSWZ2RoATSjHLFjGVW8wozahEDnkItCEmsdwtrNzW90coMY4DuHvT-yeBaee33EiMmyqpiifDqSAj-22TiKHsXlem61EE_RUkqmpoiKn647OU_0q2fwpD-Kqk4Ihyxukyq14tKBR9jMPauGozkwRvy4A15640kfvF3_XfSP2ZIArwIblxn5v-g5OrTZr1AfwNbB8ZB</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Shehram, Muhammad</creator><creator>Khalid, Hiba</creator><creator>Shafique, Hafiz Muhammad</creator><creator>Umer, Bakht</creator><creator>Zafar, Awais</creator><creator>Ullah, Asif</creator><creator>Zaidi, Syed Muhammad Jawad</creator><creator>Basit, Jawad</creator><creator>Mehmoodi, Amin</creator><creator>Malik, Jahanzeb</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9343-4187</orcidid></search><sort><creationdate>202309</creationdate><title>Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review</title><author>Shehram, Muhammad ; Khalid, Hiba ; Shafique, Hafiz Muhammad ; Umer, Bakht ; Zafar, Awais ; Ullah, Asif ; Zaidi, Syed Muhammad Jawad ; Basit, Jawad ; Mehmoodi, Amin ; Malik, Jahanzeb</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4740-c131955db60a9a433e2271032541f08f7b6544263350163ffdb0a3a79fd8187b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>anthracycline</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cardiomyopathy</topic><topic>Chemotherapy</topic><topic>Clinical trials</topic><topic>Demographics</topic><topic>diastolic dysfunction</topic><topic>Effectiveness</topic><topic>ejection fraction</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Leukemia</topic><topic>Lymphoma</topic><topic>Mortality</topic><topic>Observational studies</topic><topic>Parameters</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Review</topic><topic>Sarcoma</topic><topic>Systematic review</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shehram, Muhammad</creatorcontrib><creatorcontrib>Khalid, Hiba</creatorcontrib><creatorcontrib>Shafique, Hafiz Muhammad</creatorcontrib><creatorcontrib>Umer, Bakht</creatorcontrib><creatorcontrib>Zafar, Awais</creatorcontrib><creatorcontrib>Ullah, Asif</creatorcontrib><creatorcontrib>Zaidi, Syed Muhammad Jawad</creatorcontrib><creatorcontrib>Basit, Jawad</creatorcontrib><creatorcontrib>Mehmoodi, Amin</creatorcontrib><creatorcontrib>Malik, Jahanzeb</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley-Blackwell Open Access Backfiles</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of noninvasive electrocardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shehram, Muhammad</au><au>Khalid, Hiba</au><au>Shafique, Hafiz Muhammad</au><au>Umer, Bakht</au><au>Zafar, Awais</au><au>Ullah, Asif</au><au>Zaidi, Syed Muhammad Jawad</au><au>Basit, Jawad</au><au>Mehmoodi, Amin</au><au>Malik, Jahanzeb</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review</atitle><jtitle>Annals of noninvasive electrocardiology</jtitle><addtitle>Ann Noninvasive Electrocardiol</addtitle><date>2023-09</date><risdate>2023</risdate><volume>28</volume><issue>5</issue><spage>e13070</spage><epage>n/a</epage><pages>e13070-n/a</pages><issn>1082-720X</issn><eissn>1542-474X</eissn><abstract>Objective
The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy‐induced cardiomyopathy (CIC).
Methods
With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review.
Results
The five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.
Conclusion
CRT was associated with improvement in all patient parameters with CIC.
The five studies included a total of 169 patients who underwent CRT after CIC, which showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow‐up periods, small sample sizes, and the absence of a control group.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>37435629</pmid><doi>10.1111/anec.13070</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9343-4187</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1082-720X |
| ispartof | Annals of noninvasive electrocardiology, 2023-09, Vol.28 (5), p.e13070-n/a |
| issn | 1082-720X 1542-474X |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_ac70d436c4ef4fd68143f04a643f9722 |
| source | Open Access: Wiley-Blackwell Open Access Journals; PubMed Central |
| subjects | anthracycline Breast cancer Cancer therapies Cardiomyopathy Chemotherapy Clinical trials Demographics diastolic dysfunction Effectiveness ejection fraction Heart Heart failure Leukemia Lymphoma Mortality Observational studies Parameters Patients Quality of life Review Sarcoma Systematic review Ventricle |
| title | Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A24%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20cardiac%20resynchronization%20therapy%20in%20chemotherapy%E2%80%90induced%20cardiomyopathy:%20A%20systematic%20review&rft.jtitle=Annals%20of%20noninvasive%20electrocardiology&rft.au=Shehram,%20Muhammad&rft.date=2023-09&rft.volume=28&rft.issue=5&rft.spage=e13070&rft.epage=n/a&rft.pages=e13070-n/a&rft.issn=1082-720X&rft.eissn=1542-474X&rft_id=info:doi/10.1111/anec.13070&rft_dat=%3Cproquest_doaj_%3E2836297862%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4740-c131955db60a9a433e2271032541f08f7b6544263350163ffdb0a3a79fd8187b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2860260495&rft_id=info:pmid/37435629&rfr_iscdi=true |